| Ytd | 61.94% | |
| 1y | 208.45% |
| Open | 40.09 | Prev Close | 40.50 | Low | 40.00 | High | 40.56 | Mkt Cap | 6.27B |
| Vol | 11.27M | Avg Vol | 1.90M | EPS | -1.78 | P/E | N/A | Forward P/E | -22.75 |
| Beta | 1.12 | Short Ratio | 1.35 | Inst. Own | 96.93% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 39.77 | 200-d Avg | 29.97 | 1yr Est | 40.25 |
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medi
Major M&A deals this week include: Eli Lilly's $7.8 billion purchase of Centessa Pharmaceuti
Wall Street analysts changed outlook on top names. Dine Brands, Akamai Tech, Centessa Pharma, Methan
U.S. stocks bounce sharply on Tuesday as lower Treasury yields and Trump's signals of a potentia
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR
Eli Lilly to acquire Centessa Pharmaceuticals for $6.3B. CNTA stock surges 45% as Lilly expands its
US stocks rise, Dow Jones gains 600+ pts. Apellis Pharma shares surge 136.4% after buyout by Biogen
A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ran
U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here ar
Here's a roundup of top developments in the biotech space over the last 24 hours:
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed
During Friday's trading, 69 companies set new 52-week lows.
During the Thursday's session, 100 stocks hit new 52-week lows.
On Monday, 149 companies reached new 52-week lows.
On Monday, 198 companies reached new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.
On Monday, 524 stocks hit new 52-week lows.
On Thursday, 615 stocks hit new 52-week lows.
Toward the end of trading Monday, the Dow traded up 0.12% to 35,863.70 while the NASDAQ rose 0.18% t